Medicare Enrolled

Dr. Pankaja Achar, MD

Q: Does Dr. Achar receive payments from pharmaceutical companies?

Yes. Dr. Achar received a total of $1,081 from 11 companies across 63 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently High for Dr. Achar) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Pulmonary Disease · Newark, NJ

194 CLINTON AVE FL 2, Newark, NJ 07108

9732731515

Registered in NPPES since 2006

NPI: 1003876186 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Achar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Achar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Achar

Dr. Pankaja Achar is a pulmonary disease specialist in Newark, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Achar received a total of $1,081 from 11 pharmaceutical and/or device companies across 63 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Achar is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $1,081 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗

$1,081

Total received (2018-2023)

Avg $180/year across 6 years

Bottom 40% in NJ for pulmonary disease

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023

$139

2022

$197

2021

$289

2020

$118

2019

$188

2018

$150

Payments by company (2023)

GlaxoSmithKline, LLC.

$139

Top 3 companies account for 100.0% of 2023 payments

All-time payments by company (2018-2023) ›

GlaxoSmithKline, LLC.

$587

AstraZeneca Pharmaceuticals LP

$264

Bayer HealthCare Pharmaceuticals Inc.

$88

Janssen Pharmaceuticals, Inc

$29

Boehringer Ingelheim Pharmaceuticals, Inc.

$28

Ironshore Pharmaceuticals Inc.

$15

Merck Sharp & Dohme Corporation

$15

Gilead Sciences, Inc.

$15

Amgen Inc.

$14

Teva Pharmaceuticals USA, Inc.

$14

Mallinckrodt Hospital Products Inc.

$11

Top 3 companies account for 86.9% of all-time payments

Associated products mentioned in payments ›

ACTHAR · ANORO · ANORO ELLIPTA · BREZTRI AEROSPHERE · CINQAIR · FASENRA · Jornay 100 mg capsules (Bottle of 100) · Kerendia · LOKELMA · NUCALA · OFEV · PIFELTRO · SPIRIVA RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · Veklury · XARELTO

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a pulmonary disease specialist in Newark?
Compare pulmonary diseases in the Newark area by procedure volume, costs, and industry payment transparency.

Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas

611

County median income

$76,712

Nearest hospital to ZIP centroid (approximate)

NEWARK BETH ISRAEL MEDICAL CENTER
1.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2023
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Achar is a pulmonary disease specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Achar receive payments from pharmaceutical companies?

Yes. Dr. Achar received a total of $1,081 from 11 companies across 63 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Achar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide

Understanding Pulmonary Disease

Common procedures, typical costs, and what industry payments mean in pulmonary disease.

Same specialty & city

Pulmonary Diseases in Newark

Browse pulmonary diseases in Newark ranked by procedure volume and transparency data.

Highest volume

Top Pulmonary Diseases in NJ

Pulmonary diseases ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Pulmonary Diseases in NJ

Which NJ pulmonary diseases receive the most from drug and device companies.

By company

GlaxoSmithKline, LLC. Payments to Doctors

See all physicians who received payments from GlaxoSmithKline, LLC.

By company

AstraZeneca Pharmaceuticals LP Payments to Doctors

See all physicians who received payments from AstraZeneca Pharmaceuticals LP.

By company

Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors

See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology